KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $408.8 million.

  • Exact Sciences' Accumulated Expenses rose 3018.4% to $408.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.8 million, marking a year-over-year increase of 3018.4%. This contributed to the annual value of $328.3 million for FY2024, which is 391.91% down from last year.
  • As of Q3 2025, Exact Sciences' Accumulated Expenses stood at $408.8 million, which was up 3018.4% from $317.2 million recorded in Q2 2025.
  • Exact Sciences' Accumulated Expenses' 5-year high stood at $408.8 million during Q3 2025, with a 5-year trough of $214.1 million in Q1 2021.
  • In the last 5 years, Exact Sciences' Accumulated Expenses had a median value of $308.0 million in 2022 and averaged $309.9 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 9067.2% in 2021, then plummeted by 3390.72% in 2023.
  • Exact Sciences' Accumulated Expenses (Quarter) stood at $398.6 million in 2021, then fell by 24.92% to $299.2 million in 2022, then rose by 14.19% to $341.7 million in 2023, then dropped by 3.92% to $328.3 million in 2024, then rose by 24.52% to $408.8 million in 2025.
  • Its last three reported values are $408.8 million in Q3 2025, $317.2 million for Q2 2025, and $295.1 million during Q1 2025.